Mucoadhesive buccal film of almotriptan improved therapeutic delivery in rabbit model.
Buccal film
Eudragit
In vivo
Proloc
Rabbits
Release
Journal
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
ISSN: 1319-0164
Titre abrégé: Saudi Pharm J
Pays: Saudi Arabia
ID NLM: 9705695
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
06
07
2019
accepted:
29
11
2019
entrez:
12
2
2020
pubmed:
12
2
2020
medline:
12
2
2020
Statut:
ppublish
Résumé
Administration of almotriptan as an oral therapy is largely limited because of poor aqueous solubility and rather low bioavailability. The aim of present investigation was to formulate oral mucoadhesive film of almotriptan to improve the drug delivery and desired therapeutic effects. Placebo films (F1-F8) were prepared by varying the concentrations of Proloc 15 (7.5-15% w/v) and Eudragit RL 100/RS 100 (15-30% w/v) polymers. Physicomechanical and pharmaceutical characteristics of drug loaded films (FA1-FA4) were examined. Selected FA4 film was evaluated
Identifiants
pubmed: 32042259
doi: 10.1016/j.jsps.2019.11.022
pii: S1319-0164(19)30165-3
pmc: PMC7000341
doi:
Types de publication
Journal Article
Langues
eng
Pagination
201-209Informations de copyright
© 2019 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Adv Pharm Bull. 2013;3(1):183-8
pubmed: 24312833
Drug Deliv. 2016 Sep;23(7):2154-2162
pubmed: 25182182
Daru. 2019 Jun;27(1):59-70
pubmed: 30701460
PLoS One. 2018 Mar 22;13(3):e0194410
pubmed: 29566073
Pharmaceutics. 2019 Jan 17;11(1):
pubmed: 30658451
Springerplus. 2016 May 17;5:637
pubmed: 27330903
Drugs. 2000 Dec;60(6):1259-87
pubmed: 11152011
Pharmaceutics. 2018 Oct 24;10(4):
pubmed: 30355980
Prog Biomater. 2017 Dec;6(4):175-187
pubmed: 29110144
Drugs. 2010 Aug 20;70(12):1505-18
pubmed: 20687618
Carbohydr Polym. 2013 Jan 16;91(2):537-42
pubmed: 23121942
Pharmaceutics. 2019 Mar 01;11(3):
pubmed: 30832244
Curr Pain Headache Rep. 2002 Apr;6(2):140-6
pubmed: 11872185
Drug Deliv. 2016;23(2):471-8
pubmed: 24892626
Expert Opin Drug Deliv. 2013 Jan;10(1):131-49
pubmed: 23102011
AAPS PharmSciTech. 2017 Feb;18(1):3-14
pubmed: 27084567
Expert Opin Drug Deliv. 2010 Apr;7(4):429-44
pubmed: 20331353
Expert Opin Pharmacother. 2010 Oct;11(14):2431-6
pubmed: 20828268
J Neurol Sci. 2017 Jan 15;372:307-315
pubmed: 28017235
Drug Dev Ind Pharm. 2008 Nov;34(11):1246-66
pubmed: 18720139
Int J Pharm. 2011 Sep 15;416(1):189-94
pubmed: 21736929
Oral Dis. 2006 Jul;12(4):420-3
pubmed: 16792729
Curr Drug Deliv. 2016;13(6):882-98
pubmed: 27109335
Arch Neurol. 2002 Jul;59(7):1084-8
pubmed: 12117355
Drug Dev Res. 2018 Dec;79(8):373-382
pubmed: 30343496
CNS Drug Rev. 2002 Fall;8(3):217-34
pubmed: 12353056
Drug Dev Ind Pharm. 2010 Mar;36(3):254-82
pubmed: 19663558
Int J Gen Med. 2015 Jan 12;8:27-36
pubmed: 25624770
Drug Deliv. 2013 Jun-Jul;20(5):224-35
pubmed: 23651066
BMJ. 2014 Mar 24;348:g1416
pubmed: 24662044
Drug Dev Ind Pharm. 2014 May;40(5):625-31
pubmed: 24506459
J Pharm Biomed Anal. 2018 Jan 5;147:350-366
pubmed: 28720350
Drug Deliv. 2017 Nov;24(1):1762-1769
pubmed: 29172829
AAPS PharmSciTech. 2019 Jan 2;20(1):18
pubmed: 30603884
J Headache Pain. 2015;16:58
pubmed: 26109437
Int J Pharm. 2018 Sep 5;548(1):609-624
pubmed: 30033394
J Headache Pain. 2013 Jan 10;14:1
pubmed: 23566305
J Headache Pain. 2011 Apr;12(2):115-25
pubmed: 21210177
Curr Pain Headache Rep. 2003 Feb;7(1):55-62
pubmed: 12525272
J Pharm Sci. 2002 Sep;91(9):2016-25
pubmed: 12210048
J Headache Pain. 2012 Nov;13(8):595-606
pubmed: 23001069
J Pharm Bioallied Sci. 2014 Oct;6(4):267-77
pubmed: 25400410
Drug Dev Ind Pharm. 2019 Oct;45(10):1695-1706
pubmed: 31418592
J Control Release. 2013 Feb 28;166(1):10-21
pubmed: 23219961